Next update March 1 February 16, 2024 By ECF Hon.

New Post Public Reply Private Reply Replies (1) Message Board
freegriff
561
Next update March 1

February 16, 2024
By ECF
Hon. Loretta A. Preska
United States District Judge
Southern District of New York
500 Pearl Street
New York, NY 10007
Re: SEC v. Joshua Sason, et al., 19 Civ. 1459 (LAP)
Dear Judge Preska:
Pursuant to the Court’s January 8, 2024, Order (Dkt. 213), Plaintiff Securities and Exchange
Commission (the “Commission” or “SEC”) respectfully submits this status report, jointly with the
Defendants.
As the Court is aware, on October 30, 2023, the SEC staff and Defendants Joshua Sason,
Magna Management, LLC, Magna Equities, LLC, and MG Partners, Ltd. (collectively, the “Magna
Defendants”) agreed to recommend settlement terms to the Commission that would resolve the SEC’s
claims against the Magna Defendants. The SEC staff’s agreement to Magistrate Judge Aaron’s terms
was contingent on the SEC staff’s review and acceptance of certain information, which the SEC
received on January 4, 2024. As the parties advised the Court in our prior status letter (Dkt. 212), the
SEC planned to submit the recommended settlement to the Commission for consideration upon
receipt of executed consents to proposed final judgments by the Magna Defendants. The SEC staff
and the Magna Defendants have been negotiating certain language in the consents, but have been
unsuccessful to date in reaching an agreement. Accordingly, the SEC staff and the Magna Defendants
request that the Court set a status report deadline of two weeks from today for the parties to provide an
update concerning whether the remaining differences have been resolved.
Given the ongoing negotiations between the SEC staff and the Magna Defendants, the SEC
staff is moving forward with its recommendation to the Commission concerning resolution of the
claims against Defendant Manuel, a process which typically takes approximately six weeks.
Accordingly, the SEC and Defendant Manuel request that the Court set a deadline of March 29, 2024
for a status report as to Defendant Manuel, in the event that a proposed final judgment as to Defendant
Manuel is not filed before that date.
In light of the foregoing, the parties respectfully request that the Court set a new status report
deadline of March 1, 2024 as to the Magna Defendants and March 29, 2024 as to Defendant Manuel,
and that the deadline for a joint pretrial order (“JPTO”) remain adjourned sine die. 1
Respectfully submitted,
/s/
David Zetlin-Jones / Eric Taffet / Daniel Loss
Counsel to the SEC
cc: All counsel of record by ECF

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 393

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 220

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 298

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 110

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 150

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 188

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 331

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 318

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 361

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 227

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Carrier's $2.5 Million Commitment for Wildfire Relief Efforts

Updated Category News Views 244

Carrier's Generous Pledge for Wildfire Relief In a significant initiative aimed at supporting communities affected by wildfires, Carrier Global Corporation (NYSE: CARR), a leader in intelligent climate solutions, has announced its commitment to donate over $2.5 million worth of indoor air purifiers. This effort is specifically directed towards enhancing air quality for...

Continue Reading
Lundbeck Unveils New Insights on Multiple System Atrophy

Updated Category News Views 358

Lundbeck Reveals Insights into Multiple System Atrophy at International Congress VALBY, Denmark – H. Lundbeck A/S (Lundbeck) is set to present pivotal pipeline data and invaluable patient perspectives from the recent AMULET trial, highlighting amlenetug as a promising treatment for the rare neurological disorder known as multiple system atrophy (MSA). This significant...

Continue Reading
Keenova Therapeutics: A New Era for Mallinckrodt's Spin-Off

Updated Category News Views 599

Welcome to Keenova Therapeutics In an exciting announcement, Mallinckrodt plc has successfully completed the planned spin-off of its Par Health generic pharmaceuticals and sterile injectables businesses. As of now, the company will operate under the new name, Keenova Therapeutics, dedicating its efforts towards developing and delivering innovative therapies for patients...

Continue Reading
BlackRock, Inc. Increases Shareholding in Ageas to 7.78%

Updated Category News Views 154

Recent Financial Developments at Ageas In an important disclosure regarding financial transparency, BlackRock, Inc. has officially notified Ageas that it has exceeded the legal threshold of 5% ownership in the company, with its current shareholding reaching an impressive 7.78%. This notification was made in accordance with regulatory requirements aimed at maintaining...

Continue Reading
AKWEL Reports Revenue Decline in Nine-Month Financial Update

Updated Category News Views 48

Decline in Revenue for AKWEL in Recent Financial Update AKWEL, a key player in the automotive and heavy-vehicle parts market, has announced a notable decline in their financial performance for the first nine months of the year. The company, specializing in fluid management and structural parts for electric vehicles, has reported a consolidated revenue of €757.7 million,...

Continue Reading